PCVX Crosses Above Average Analyst Target
September 17, 2020 at 08:20 AM EDT
In recent trading, shares of Vaxcyte Inc (PCVX) have crossed above the average analyst 12-month target price of $46.50, changing hands for $48.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..